OOIR: Observatory of International Research

Papers

(The H4-Index of Thorax is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Vaping and CBD: can new technology overcome old problems?	261
Case-based discussion: neonates on extracorporeal membrane oxygenation for undiagnosed recalcitrant pulmonary hypertension—management challenges	178
Rectal organoid morphometric analysis (ROMA)—re: optimising measurements automatically	122
E-cigarette use in young adults and adolescents: not so safe?	101
Fibrosing mediastinitis: ‘haemoptysis in the Heartland’	97
Ablation for lung cancer: hot or cold intervention	92
Correction: British Thoracic Society Winter Meeting 2023	90
Complex coexistence of COPD and cardiovascular disease	85
TB PCR in BAL and EBUS-TBNA samples for the diagnosis of pulmonary and mediastinal lymph node TB: retrospective TRiBE study	73
Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data	68
Upstaging of screen-detected lung cancers during diagnostic assessment	67
At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation	66
Lung development genes, adult lung function and cardiovascular comorbidities	64
Comparative cost-effectiveness of screening for lung cancer using different risk scores and thresholds: the Yorkshire Lung Screening Trial	62
Strengthening the evidence base to support stronger regulation of social media based advertising of e-cigarette products to youth	60
Ultrafine particles and health: the next frontier in understanding air pollution hazards	58
Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline	55
What constitutes meaningful gain in skeletal muscle strength in COPD?	53
Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma	52
Is the provision of a national opt-out tobacco dependence treatment service in acute hospitals in England equitable? A national cohort study	47
Mechanisms driving immunopathogenesis of viral exacerbations in chronic respiratory disease	47
British Thoracic Society Guideline for pleural disease	45
Toxic metals and lung health: silent poisons?	44
Paediatric asthma hospitalisations continue to decrease in Finland and Sweden between 2015 and 2020	41
Beyond detection: what happens after lung cancer screening matters more	41

Muscle memory: genetic factors underlying functional impairment in COPD	41
Ageing and ivacaftor: unravelling the long-term effects	40
Stretching the diagnosis: tracheobronchomegaly in alpha-1 antitrypsin deficiency or coexisting Mounier-Kuhn syndrome?	38
Delayed presentation of pulmonary Echinococcus in a patient with no major risk factors	37
‘Mind the gap’	36
Smartphones: a useful option for the pulmonary rehab toolkit?	36
Global asthma and pest control: bugs and WASPs	35
CTHRC1: a serum biomarker for a pathological fibroblast in IPF	34
Non-invasive ventilation: interpretation of ventilator supplied data	34
Correction: RAGE-induced ILC2 expansion in acute lung injury due to haemorrhagic shock	34